(Q40143249)

17 September 2017

1 reference

title

Treatment of common lipoprotein disorders (English)

1 reference

Cardiology and cardiovascular medicine

17 September 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

30 September 2023

author name string

W. V. Brown

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6330792

30 September 2023

I. J. Goldberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6330792

30 September 2023

H. N. Ginsberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6330792

30 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6330792

30 September 2023

publication date

1 July 1984

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0033062084900173?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

https://api.elsevier.com/content/article/PII:0033062084900173?httpAccept=text/plain

30 September 2023

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Progress in Cardiovascular Diseases

30 September 2023

published in

1 reference

17 September 2017

volume

27

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

1-20

1 reference

Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese Men

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

The evidence for the antiatherogenicity of high density lipoprotein in man

30 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

30 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Atherosclerosis regression in animal models: current concepts of cellular and biochemical mechanisms

30 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

30 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women.

30 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men

30 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

30 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease

30 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California

30 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Serum cholesterol levels of Mexican and Wisconsin school children

30 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

30 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis

30 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Disorders of lipid transport--update 1983.

30 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Principles of nutrition and dietary recommendations for individuals with diabetes mellitus: 1979. American Diabetes Association

30 September 2023

36

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

The Dietary Treatment of Hyperlipidemia: Rationale, Technique and Efficacy

30 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Plasma apoprotein and lipoprotein lipid levels in vegetarians

30 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Lipoprotein metabolism in nonresponders to increased dietary cholesterol

30 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effects of dietary cholesterol and fatty acids on plasma lipoproteins

30 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.

30 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Serum cholesterol response to changes in the diet: I. Iodine value of dietary fat versus 2S-P

30 September 2023

43

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

The effects of unsaturated dietary fats on absorption, excretion, synthesis, and distribution of cholesterol in man

30 September 2023

44

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Polyunsaturated Ruminant Fats and Cholesterol Metabolism in Man

30 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia

30 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet

30 September 2023

50

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Bias and misrepresentation revisited: Perspective" on saturated fat

30 September 2023

53

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Carbohydrate-induced and fat-induced lipemia

30 September 2023

54

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Fiber and pectin in the diet and serum cholesterol concentration in man

30 September 2023

55

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effects of obesity and caloric intake on biliary lipid metabolism in man

30 September 2023

56

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women

30 September 2023

57

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Obesity and lipoprotein cholesterol in the Framingham offspring study.

30 September 2023

58

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Overweight and hypertension. A review

30 September 2023

59

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

30 September 2023

60

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Dietary determinants of plasma cholesterol change in the recruitment phase of the Lipid Research Clinics Coronary Primary Prevention Trial

30 September 2023

62

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.

30 September 2023

63

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Apolipoprotein B metabolism in normal, type IV and type V hyperlipoproteinemic subjects

30 September 2023

64

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Evidence for diabetes mellitus and genetic forms of hypertriglyceridemia as independent entities

30 September 2023

66

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Plasma triglyceride and insulin levels in familial hypertriglyceridemia

30 September 2023

67

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Transport of Very Low Density Lipoprotein Triglycerides in Varying Degrees of Obesity and Hypertriglyceridemia

30 September 2023

68

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia

30 September 2023

69

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects

30 September 2023

70

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Unexpected decrease in plasma high density lipoprotein cholesterol with weight loss

30 September 2023

71

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Plasma lipoprotein distributions in male and female runners

30 September 2023

72

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Serum Triglycerides and Cholesterol and Serum High-Density Lipoprotein Cholesterol in Highly Physically Active Men

30 September 2023

73

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

The effect of cholestyramine on the faecal excretion of bile acids and neutral steroids in familial hypercholesterolaemia

30 September 2023

76

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

The LDL Receptor Defect in Familial Hypercholesterolemia: Implications for Pathogenesis and Therapy

30 September 2023

77

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism

30 September 2023

78

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Hypolipidemic drugs and hyperlipoproteinemia

30 September 2023

80

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.

30 September 2023

82

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen

30 September 2023

83

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia

30 September 2023

84

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia

30 September 2023

85

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV

30 September 2023

89

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effect of nicotinic acid on catabolism and synthesis of cholesterol in man

30 September 2023

90

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effect of treatment with nicotinic acid for one month on serum lipids in patients with different types of hyperlipidemia.

30 September 2023

91

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A Metabolism

30 September 2023

92

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Treatment of hypercholesterolemia.

30 September 2023

93

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis

30 September 2023

94

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia

30 September 2023

96

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effect of probucol on the activity of postheparin plasma lipoprotein lipase and hepatic lipase

30 September 2023

98

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Sensitization to epinephrine-induced ventricular fibrillation produced by probucol in dogs

30 September 2023

99

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Action of neomycin on the intraluminal phase of lipid absorption

30 September 2023

100

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effects of neomycin on absorption, synthesis, and/or flux of cholesterol in man

30 September 2023

101

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effect of neomycin on exchangeable pools of cholesterol in the steady state

30 September 2023

102

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effects of Neomycin Alone and in Combination with Cholestyramine on Serum Cholesterol and Fecal Steroids in Hypercholesterolemic Subjects

30 September 2023

103

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Treatment of Hypercholesterolemia with Neomycin — A Time for Reappraisal

30 September 2023

104

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Turnover of low density lipoproteins during inhibition of cholesterol absorption by neomycin

30 September 2023

105

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effects and side-effects of treatment of hypercholesterolemia with cholestyramine and neomycin

30 September 2023

106

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Thyroid hormones and plasma lipids

30 September 2023

107

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts

30 September 2023

110

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo

30 September 2023

111

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy

30 September 2023

112

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Treatment of hyperlipidemias

30 September 2023

115

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Dextrothyroxine with propranolol in treatment of hypercholesterolaemia

30 September 2023

116

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine

30 September 2023

117

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog

30 September 2023

118

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers

30 September 2023

122

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia

30 September 2023

123

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Mechanism of the hypolipemic effect of clofibrate in postabsorptive man

30 September 2023

125

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

The effect of treatment with clofibrate on hepatic triglyceride and lipoprotein lipase activities of post heparin plasma in male patients with hyperlipoproteinemia

30 September 2023

127

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

30 September 2023

129

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Acute Muscular Syndrome Associated with Administration of Clofibrate

30 September 2023

130

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Menopausal oestrogen therapy and protection from death from ischaemic heart disease

30 September 2023

132

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effects of oxandrolone on plasma triglycerides and postheparin lipolytic activity in patients with types III, IV, and V familial hyperlipoproteinemia

30 September 2023

134

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons

30 September 2023

135

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Effect of Oxandrolone Treatment on the Activity of Lipoprotein Lipase, Hepatic Lipase and Phospholipase a1of Human Postheparin Plasma

30 September 2023

136

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia

30 September 2023

137

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

Type III Hyperlipoproteinemia: Paradoxical Hypolipidemic Response to Estrogen

30 September 2023

138

1 reference

https://api.crossref.org/works/10.1016/0033-0620(84)90017-3

30 September 2023

Identifiers

1 reference

17 September 2017

1 reference